drugset / Trial / NCT00539630
TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN
RandomizedSingle-groupOpen-labelTreatment
Summary
To describe the clinical response rate in two groups (Docetaxel plus cisplatin plus 5-FU, versus Cisplatin plus 5-FU) after 3 cycle of neoadjuvant chemotherapy.
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | — | — |